Clinical Pharmacology

E-mail this page

(All fields required)

Please enter a valid email.

Please enter your name.

Please enter a valid email.

Clinical Pharmacology

 

Division Publications

  1. Brandhorst G, Oellerich M, Brunet M, Kowalski R, Vinks A, Wallemacq P. Individually tailored immunosuppression: is there a role for biomarkers?. Clin Chem. 2011; 57:376-81.
  2. Fukuda T, Goebel J, Thogersen H, Maseck D, Cox S, Logan B, Sherbotie J, Seikaly M, Vinks AA. Inosine monophosphate dehydrogenase (IMPDH) activity as a pharmacodynamic biomarker of mycophenolic acid effects in pediatric kidney transplant recipients. J Clin Pharmacol. 2011; 51:309-20.
  3. Gerlach LS, Saldana SN, Wang Y, Nick TG, Spigarelli MG. Retrospective review of the relationship between weight change and demographic factors following initial depot medroxyprogesterone acetate injection in adolescents. Clin Ther. 2011; 33:182-7.
  4. Harris E, Eng HY, Kowatch R, Delgado SV, Saldana SN. Disinhibition as a side effect of treatment with fluvoxamine in pediatric patients with obsessive-compulsive disorder. J Child Adolesc Psychopharmacol. 2010; 20:347-53.
  5. Li Z, Wang L, Wang Y, Gui YH, Vinks AA, MacLeod S. Better medicines for 300 million children in China: report on recent progress. Paediatr Drugs. 2011; 13:137-40.
  6. Mehta PA, Vinks AA, Filipovich A, Bleesing J, Jodele S, Jordan MB, Marsh R, Tarin R, Edwards S, Fearing D, Lawrence J, Davies SM. Alternate-day micafungin antifungal prophylaxis in pediatric patients undergoing hematopoietic stem cell transplantation: a pharmacokinetic study. Biol Blood Marrow Transplant. 2010; 16:1458-62.
  7. Sagcal-Gironella AC, Fukuda T, Wiers K, Cox S, Nelson S, Dina B, Sherwin CM, Klein-Gitelman MS, Vinks AA, Brunner HI. Pharmacokinetics and pharmacodynamics of mycophenolic acid and their relation to response to therapy of childhood-onset systemic lupus erythematosus. Semin Arthritis Rheum. 2011; 40:307-13.
  8. Sherwin CM, Fukuda T, Brunner HI, Goebel J, Vinks AA. The evolution of population pharmacokinetic models to describe the enterohepatic recycling of mycophenolic acid in solid organ transplantation and autoimmune disease. Clin Pharmacokinet. 2011; 50:1-24.
  9. Soldin OP, Soldin SJ, Vinks AA, Younis I, Landy HJ. Longitudinal comparison of thyroxine pharmacokinetics between pregnant and nonpregnant women: a stable isotope study. Ther Drug Monit. 2010; 32:767-73.
  10. Tett SE, Saint-Marcoux F, Staatz CE, Brunet M, Vinks AA, Miura M, Marquet P, Kuypers DR, van Gelder T, Cattaneo D. Mycophenolate, clinical pharmacokinetics, formulations, and methods for assessing drug exposure. Transplant Rev (Orlando). 2011; 25:47-57.
  11. Tonshoff B, David-Neto E, Ettenger R, Filler G, van Gelder T, Goebel J, Kuypers DR, Tsai E, Vinks AA, Weber LT, Zimmerhackl LB. Pediatric aspects of therapeutic drug monitoring of mycophenolic acid in renal transplantation. Transplant Rev (Orlando). 2011; 25:78-89.
  12. Vinks AA, Saldana SN. Developmental principles of pharmacokinetics. Pediatric psychopharmacology : principles and practice. New York: Oxford University Press; 2010:38-49.
Please give to Cincinnati Children's.
US-News-Honor-Roll-FooterBest Places to Work Logo

3333 Burnet Avenue, Cincinnati, Ohio 45229-3026 | 1-513-636-4200 | 1-800-344-2462 | TTY:1-513-636-4900

New to Cincinnati Children’s or live outside of the tri-state area? 1-877-881-8479

© 1999-2013 Cincinnati Children's Hospital Medical Center